Institutional Members Directory


The mission of the Association of Clinical Research Professionals is to provide global leadership to promote integrity and excellence for the clinical research profession.
ACRP is the primary resource for clinical research professionals in the pharmaceutical, biotechnology and medical device industries, and those in hospital, academic medical centers and physician office settings. ACRP was founded in 1976 to address the distinct educational and networking needs of research nurses and others who supported the work of clinical investigations. With its own professional society came the recognition of a new distinctive profession — that of the clinical researcher. More than 30 years later, ACRP is a global association comprised of more than 18,000 individuals in over 60 countries dedicated to clinical research and development.



Clinical trials at university hospitals are increasingly important for the management of patients’ health.
It is a real challenge to conduct the trials in compliance with good clinical practice and research guidelines and regulations, in a scientific and technical environment which performs well because of a thorough organisation and qualified staff. This requires up-to-date knowledge and training opportunities for the institution and its staff. The Centre Hospitalier Universitaire Brugmann finds that the EFGCP activities create a stimulating environment which helps it fulfill its research mission.



The Luxembourg Institute of Health(, is the leading public organization for basic, pre-clinical & clinical research in life sciences in Luxembourg. In line with the major health challenges defined at EU (DG-Sanco) and national levels (National Health Plan), The Luxembourg Institute of Health mission is to generate knowledge on the pathogenesis, diagnosis, treatment of diseases with large impact on public health & to perform epidemiological surveillance of these diseases & research on related health determinants in the population. As a consequence, the Luxembourg Institute of Health positions itself strategically at the interface of laboratory, clinical and public health research with the goal of creating value for the Luxembourg society. The Luxembourg Institute of Health is also leveraging its competences in clinical research & contributing to higher education (Master and PhD training) in collaboration with national and foreign universities. The Luxembourg Institute of Health's research activities are developed within the following five thematic research departments: (i) Cardiovascular diseases, (ii) Immunology, (iii) Oncology, (iv) Public Health, (v) Virology, Allergology & Immunity. CRP-Santé has 200 scientific & 50 support staff, who performed in 2009 more than 103 research projects and published 98 peer-reviewed papers with an average impact factor above 6. Read more...



The European AIDS Treatment Group (EATG) is a European network of nationally-based volunteer activists comprising of more than 110 members from 40 countries in Europe. The members are representatives of different communities affected by HIV/AIDS in Europe.
EATG, within the remit of the European Community Advisory Board (ECAB) and the Policy Working Group aims to promote the harmonisation of the best available clinical practices, standards of care and access to the latest and best available therapies and diagnostic tools throughout Europe, with a particular regard to Central and Eastern Europe.
Since its foundation in 1992, the EATG has been at the forefront of the development of the civil society response to the HIV/AIDS epidemic in Europe. It represents and defends the treatment-related interests of people living with HIV/AIDS. Our activities focus on treatment literacy and treatment advocacy. A major goal for EATG was the simultaneous development of therapies in Europe, including not only antiretroviral therapies, but as well as treatments for opportunistic infections and other AIDS related conditions.



The European Group for Blood and Marrow Transplantation (EBMT) is a non-profit organisation that was established in 1974 in order to allow scientists and physicians involved in bone marrow transplantation to share their experience and develop co-operative studies. The EBMT is devoted to the promotion of all aspects associated with the transplantation of haematopoietic stem cells from all donor sources and donor types including basic and clinical research, education, standardisation, quality control, and accreditation for transplant procedures. The EBMT is made up of over 4,000 members based in over 500 transplant centres in countries worldwide.
The EBMT’s mission is to “Foster excellence in science in order to further improve the outcomes of Stem Cell Transplantation and inform all concerned parties including patients and their families, about the development in the field.” Read more...



The European Clinical Research Infrastructures Network (ECRIN, is a sustainable, not-for-profit infrastructure supporting multinational clinical research projects driven by academic investigators and biotech or medical device SMEs in Europe. It is dedicated to improving the health of patients and citizens across the world through clinical research.

ECRIN is funded by Europe’s 7th Framework Programme and is one of the ESFRI (European Strategy Forum on Research Infrastructures)-roadmap biologic and medical research infrastructures.

ECRIN provides academic investigators and biotechnology or medical device SME sponsors with information to support the design and the preparation of the study then, based on scientific excellence, with cost-effective consulting and services to conduct multinational trials in Europe



The European Organisation for the Research and Treatment of Cancer (EORTC) unites cancer clinical research experts to define better treatments for cancer patients to prolong survival and improve quality of life.

Both international and multidisciplinary, EORTC’s Network comprises over 4600 collaborators involved in cancer treatment and research in more than 800 hospitals across 35 countries.

Through translational and clinical research, EORTC offers an integrated approach to therapeutic strategies, drug evaluation programs, survivorship issues, and quality of life.
EORTC Headquarters, a unique international clinical research infrastructure, is based in Brussels, Belgium, from where its various activities are coordinated and run.

The EJC ( is the official journal of the EORTC.



ESA resulted from the amalgamation of the former European Society of Anaesthesiologists (ESA), the European Academy of Anaesthesiology (EAA) and the Confederation of European National Societies of Anaesthesiologists (CENSA) and holds the most prominent position in the community of anaesthesiologists in Europe and elsewhere with more than 4000 individual members and more than 32 National Anaesthesia Societies representing more than 75.000 anaesthetists in Europe. The Society is governed by a Board of Directors, a Council and the General Assembly.

Its mission statement is to aim for the highest standards of practice and safety in anaesthesia, intensive care, emergency medicine and pain treatment through education, research and professional development throughout Europe.  Read more...



The European Society of Oncology Pharmacy, founded in 2000 in Prague, is the largest organisation of oncology pharmacists in the world with over 3200 members from 48 countries.

Aim and Objectives
ESOP supports optimal treatment for cancer patients with objectives to develop and promote clinical and oncology pharmacy practice through:

1. Education and training;
2. Safe handling and administration of drugs;
3. Quality management;
4. Research and development;
5. Pharmaceutical care.

The Oncology Team – Co-operation
The pharmacy as coordinator of Centre of Cytotoxic Therapy implements quality management of oncology pharmacy services and takes responsibility in patient care and personnel protection regarding all areas of cytotoxic therapy. The pharmacy collects and processes all medical and toxicological data relevant to cytotoxics, as well as supportive measures. Focusing on cytotoxic treatment alone is not enough. We also need to focus on appropriate diet, adequate analgesic medication and correct anti-emetic scheme, and we cannot ignore the social and psychological needs of the patient.
Financial resources have become limited, and it is necessary to intensify our services to increase cost effectiveness, to ensure adequate treatment and to prevent quality loss.



The Ethics Committee of the Medical University of Vienna is the research ethics committee of the largest university hospital in Austria, which is one of the largest hospitals in Europe. The committee handles about 1200 clinical research projects per year, the majority of which are academic studies. It fulfills its three-faceted role of protecting patients, supporting researchers and providing assurance to the general public, with special focus on clinical research in the academic environment.
Constantly involved in the evaluation and supervision of academic resesarch projects, the committee conceives its professional role not only as acting at local level, but also to function as a sounding board for the particular needs and requirements of academic research on national and European level.



As a unique alliance of NGOs and pharmaceutical companies, EURADIA’s mission is to improve the lives of people affected by diabetes both now and in the future, through advocacy of diabetes research in Europe at the highest political and societal levels of influence, and by shaping the allocation of resources for diabetes research in Europe through increased awareness.

Diabetes in its two major forms is a complex, multisystem, polygenic disease that is complicated to treat and pervades all areas of health services. It is common, affects people of every age and is exacerbated by lifestyle factors in many cases. The complications are devastating and can be life-threatening. Better-targeted approaches to research funding as well as a more coordinated response to emerging health needs and research opportunities are necessary. Read more...



The GIMEMA (Italian Group for Haematological Diseases in Adults) began in 1982, with a small group of Italian haematology centres, which realised that only by joining forces and comparing case studies could they achieve results of any significance, which they would not otherwise have been able to do.
It was the start of a journey, one which has brought about unexpected successes. Over the years it has also given rise to the establishment of a network to which almost all Italian haematology centres, and all the various diseases they deal with, belong. Membership requires only two strict undertakings: the rigorous observation of clinical research protocols and the proper collation of results.



© EFGCP aisbl  - cheap Ugg Boots Sale,cheap UggsAll rights reserved - Terms of Use